References
- Brait VH, Arumugam TV, Drummond GR, et al. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab. 2012;32:598–611.
- Kim T, Vemuganti R. Mechanisms of Parkinson’s disease-related proteins in mediating secondary brain damage after cerebral ischemia. J Cereb Blood Flow Metab. 2017;37:1910–1926.
- Vespa P, Bergsneider M, Hattori N, et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab. 2005;25:763–774.
- Zhang H, Meng LZ, Lyon R, et al. Monitoring cerebral ischemia during cerebrovascular surgery. J Biomed Res. 2017;31:279–282.
- Park SY, An SA, Lee HB, et al. Different impact of hyperhomocysteinemia on cerebral small vessel ischemia and cervico-cerebral atherosclerosis in non-stroke individuals. Thromb Res. 2013;131:e12–16.
- Schimidt HL, Vieira A, Altermann C, et al. Memory deficits and oxidative stress in cerebral ischemia–reperfusion: neuroprotective role of physical exercise and green tea supplementation. Neurobiol Learn Mem. 2014;114:242–250.
- Wang H, Tri Anggraini F, Chen X, et al. Embryonic lethal abnormal vision proteins and adenine and uridine-rich element mRNAs after global cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab. 2017;37:1494–1507.
- Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149.
- Sekhon MS, Ainslie PN, Griesdale DE. Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a “two-hit” model. Crit Care. 2017;21:90.
- Lu Y, Yang JH, Li X, et al. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem Pharmacol. 2011;82:1700–1708.
- Su J, Yan Y, Qu J, et al. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway . Oncol Rep. 2017;37:1565–1572.
- Tian SL, Yang Y, Liu XL, et al. Emodin attenuates bleomycin-induced pulmonary fibrosis via anti-inflammatory and anti-oxidative activities in rats. Med Sci Monit. 2018;24:1–10.
- Janeczko M, Masłyk M, Kubiński K, et al. Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida albicans. Yeast. 2017;34:253–265.
- Zhao XA, Chen G, Liu Y, et al. Emodin alleviates liver fibrosis of mice by reducing infiltration of Gr1(hi) monocytes. Evidence-Based Complement Alternat Med. 2018;2018:1–5738101.
- Li L, Sheng X, Zhao S, et al. Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia. Purinergic Signal. 2017;13:559–568.
- Li Y, Wang L, Tu Y, et al. A new dosage form of emodin: for solubility and dissolution rate enhancement and application in Alzheimer’s disease and bacteriostasis. J Drug Deliv Sci Technol. 2015;29:261–268.
- Liu T, Jin H, Sun QR, et al. Neuroprotective effects of emodin in rat cortical neurons against beta-amyloid-induced neurotoxicity. Brain Res. 2010;1347:149–160.
- Xu J, Wang Y, Tan X, et al. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy. 2012;8:873–882.
- Ouyang YB, Stary CM, Yang GY, et al. microRNAs: innovative targets for cerebral ischemia and stroke. Curr Drug Targets. 2013;14:90–101.
- Xiang H, Tao X, Xia S, et al. Emodin alleviates sodium taurocholate-induced pancreatic acinar cell injury via microRNA-30a-5p-mediated inhibition of high-temperature requirement A/transforming growth factor beta 1 inflammatory dignaling. Front Immunol. 2017;8:1488–1488.
- Pan L, Huang BJ, Ma XE, et al. MiR-25 protects cardiomyocytes against oxidative damage by targeting the mitochondrial calcium uniporter. Int J Mol Sci. 2015;16:5420–5433.
- Liu Q, Wang Y, Yang T, et al. Protective effects of miR-25 against hypoxia/reoxygenation-induced fibrosis and apoptosis of H9c2 cells. Int J Mol Med. 2016;38:1225–1234.
- Weng H, Pan A, Yang L, et al. Estimating number of transgene copies in transgenic rapeseed by real-time PCR assay withHMG I/Y as an endogenous reference gene. Plant Mol Biol Rep. 2004;22:289–300.
- Pecere T, Gazzola MV, Mucignat C, et al. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 2000;60:2800–2804.
- Ho SL, Poon CY, Lin C, et al. Inhibition of beta-amyloid aggregation by albiflorin, aloeemodin and neohesperidin and their neuroprotective effect on primary hippocampal cells against beta-amyloid induced toxicity. Curr Alzheimer Res. 2015;12:424–433.
- Lu X, Gu R, Hu W, et al. Upregulation of heme oxygenase-1 protected against brain damage induced by transient cerebral ischemia-reperfusion injury in rats. Exp Ther Med. 2018;15:4629–4636.
- Shu S, Li CM, You YL, et al. Electroacupuncture ameliorates cerebral ischemia-reperfusion injury by regulation of autophagy and apoptosis. Evid Based Complement Alternat Med. 2016;2016:7297425.
- Chen D, Liu J, Lu L, et al. Emodin attenuates TNF-α-induced apoptosis and autophagy in mouse C2C12 myoblasts though the phosphorylation of Akt. Int Immunopharmacol. 2016;34:107–113.
- Hua JY, He YZ, Xu Y, et al. Emodin prevents intima thickness via Wnt4/Dvl-1/beta-catenin signaling pathway mediated by miR-126 in balloon-injured carotid artery rats. Exp Mol Med. 2015;47:e170.
- Guo Y, Niu S. MiR-25 protects PC-12 cells from H2O2 mediated oxidative damage via WNT/β-catenin pathway . J Spinal Cord Med. 2018;41:416–425.
- Zhang JF, Shi LL, Zhang L, et al. MicroRNA-25 negatively regulates cerebral ischemia/reperfusion injury-induced cell apoptosis through Fas/FasL pathway. J Mol Neurosci. 2016;58:507–516.
- Capasso M, Diskin S, Cimmino F, et al. Common genetic variants in NEFL influence gene expression and neuroblastoma risk. Cancer Res. 2014;74:6913–6924.
- Huang Z, Zhuo Y, Shen Z, et al. The role of NEFL in cell growth and invasion in head and neck squamous cell carcinoma cell lines. J Oral Pathol Med. 2014;43:191–198.
- Ishtiaq M, Campos-Melo D, Volkening K, et al. Analysis of novel NEFL mRNA targeting microRNAs in amyotrophic lateral sclerosis. PLoS One. 2014;9:e85653.
- Peng G, Yuan X, Yuan J, et al. miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. Mol Cell Biochem. 2015;409:103–111.
- Fu L, Huang L, Cao C, et al. Inhibition of AMP-activated protein kinase alleviates focal cerebral ischemia injury in mice: interference with mTOR and autophagy. Brain Res. 2016;1650:103–111.
- Wei Z, Chigurupati S, Arumugam TV, et al. Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia. Stroke. 2011;42:2589–2594.
- Gao R, Chen R, Cao Y, et al. Emodin suppresses TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells through Notch signaling pathway. Toxicol Appl Pharmacol. 2017;318:1–7.